F
Fabrice Bauer
Researcher at French Institute of Health and Medical Research
Publications - 145
Citations - 8234
Fabrice Bauer is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Heart failure & Stenosis. The author has an hindex of 35, co-authored 130 publications receiving 7493 citations. Previous affiliations of Fabrice Bauer include Core Laboratories & University of Rouen.
Papers
More filters
Journal ArticleDOI
Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis First Human Case Description
Alain Cribier,Hélène Eltchaninoff,Assaf Bash,Nicolas Borenstein,Christophe Tron,Fabrice Bauer,Geneviève Derumeaux,Frédéric Anselme,François Laborde,Martin B. Leon +9 more
TL;DR: A percutaneous implantable prosthetic heart valve (PHV) composed of 3 bovine pericardial leaflets mounted within a balloon-expandable stent was developed in this article.
Journal ArticleDOI
Treatment of Calcific Aortic Stenosis With the Percutaneous Heart Valve: Mid-Term Follow-Up From the Initial Feasibility Studies: The French Experience
Alain Cribier,Hélène Eltchaninoff,Christophe Tron,Fabrice Bauer,Carla Agatiello,Deborah Nercolini,Sydney Tapiero,Pierre Yves Litzler,Jean Paul Bessou,Vasilis Babaliaros +9 more
TL;DR: Percutaneous heart valve implantation is feasible in inoperable patients with end-stage AS leading to hemodynamic and clinical improvement, and Continued advances and improved patient selection should decrease adverse events in the near future.
Journal ArticleDOI
Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis
Alain Cribier,Hélène Eltchaninoff,Christophe Tron,Fabrice Bauer,Carla Agatiello,Laurent Sebagh,Assaf Bash,Danielle Nusimovici,Pierre-Yves Litzler,Jean-Paul Bessou,Martin B. Leon +10 more
TL;DR: Implantation of the PHV can be achieved in patients with end-stage calcific aortic stenosis and might become an important therapeutic option for patients not amenable to surgical valve replacement.
Journal ArticleDOI
Aortic valve replacement for Low-Flow/Low-Gradient aortic stenosis - Operative risk stratification and long-term outcome: A European Multicenter study
Franck Levy,M. Laurent,Jean Luc Monin,Jean Michel Maillet,Agnes Pasquet,Thierry Le Tourneau,Hélène Petit-Eisenmann,Mauro Gori,Yannick Jobic,Fabrice Bauer,Christophe Chauvel,A. Leguerrier,Christophe Tribouilloy +12 more
TL;DR: In view of the very poor prognosis of unoperated patients, the current operative risk, and the long-term outcome after surgery, AVR is the treatment of choice in the majority of cases of LF/LGAS.
Journal ArticleDOI
Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery
Jian Xin,Takahiro Shiota,Harry M. Lever,Samir R. Kapadia,Marta Sitges,David N. Rubin,Fabrice Bauer,Neil L. Greenberg,Deborah A. Agler,Jeanne K. Drinko,Maureen Martin,Murat Tuzcu,Nicholas G. Smedira,Bruce W. Lytle,James D. Thomas +14 more
TL;DR: Both myectomy and PTSMA reduce LVOT obstruction and significantly improve the New York Heart Association functional class in patients with HOCM.